RNAZ$1.58-3.07%
Transcode Therapeutics, Inc.
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
Mkt Cap:$26.75M
Float & O/S:
Inst Own:
DilutionScan read 29 of Transcode Therapeutics, Inc.'s SEC filings and found 16 warrant series, 6 convertibles, 1 equity line, 3 shelf registrations, 2 S-1 registrations and 4 completed offerings on file for RNAZ. The latest dilution event on file is an offering on Jul 22, 2026. Analysis updated Oct 14, 2026.
